Si-bone, INC Form 4 insider transactions

SI-BONE's Chief Financial Officer, Anshul Maheshwari, sold 1,300 shares of common stock in pre-arranged transactions.

SI-BONE's President of Commercial Operations, Anthony J. Recupero, sold shares to cover tax withholding obligations related to restricted stock unit vesting.

SI-BONE's SVP and Chief Legal Officer, Michael A. Pisetsky, sold 3,328 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

SI-BONE's Chief Financial Officer, Anshul Maheshwari, sold 3,460 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

SI-BONE, Inc. CEO Laura Francis reported the sale of 16,752 shares of common stock in pre-planned transactions to cover tax obligations and under a 10b5-1 trading plan.

SI-BONE, Inc. CEO Laura Francis sold 5,411 shares of common stock for a weighted-average price of $17.0591 per share under a pre-arranged 10b5-1 trading plan.

SI-BONE Director Jeffrey W. Dunn executed pre-planned stock option exercises and subsequent sales of common stock on November 11, 2025.

SI-BONE, Inc.'s Chief Financial Officer, Anshul Maheshwari, reported the sale of 2,601 shares of common stock under a pre-arranged 10b5-1 trading plan.

SI-BONE Director Jeffrey W. Dunn has filed a Form 4 indicating a planned sale of 293 shares of common stock on November 3, 2025, to cover tax withholding obligations from restricted stock unit vesting.

SI-BONE's SVP, Ops & Adm/Chief Legal Officer, Michael A. Pisetsky, sold common stock on October 2, 2025, to cover tax withholding obligations from restricted stock unit vesting.

SI-BONE's Chief Financial Officer, Anshul Maheshwari, sold 3,311 shares of common stock on October 2, 2025, to cover tax withholding obligations related to restricted stock unit vesting.

SI-BONE's President of Commercial Operations, Anthony J. Recupero, sold shares to cover tax withholding obligations related to restricted stock unit vesting.

SI-BONE's President of Commercial Operations, Anthony J. Recupero, sold shares to cover tax withholding obligations related to RSU vesting.

SI-BONE's SVP, Operations & Administration/Chief Legal Officer, Michael A. Pisetsky, sold 3,329 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

SI-BONE, Inc.'s Chief Financial Officer, Anshul Maheshwari, sold 3,461 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

SI-BONE, Inc. CEO Laura Francis sold 11,343 shares of common stock on August 18, 2025, solely to cover tax withholding obligations related to restricted stock unit vesting.

SI-BONE, Inc. Director John G. Freund reported the sale of 12,132 shares of common stock for approximately $194,000, executed under a Rule 10b5-1 trading plan.

SI-BONE, Inc. Director Jeffrey W. Dunn sold 293 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

SI-BONE, Inc.'s Chief Financial Officer, Anshul Maheshwari, filed an amended Form 4 to correct an administrative error, reducing the reported number of shares sold in a July 2025 transaction.

SI-BONE, Inc. CEO and Director Laura Francis reported a planned sale of 757 shares of common stock at $18.26 per share, executed under a 10b5-1 trading plan, alongside a transfer of shares to a joint revocable trust.

SI-BONE, Inc.'s Chief Financial Officer, Anshul Maheshwari, sold 5,005 shares of common stock on July 2, 2025, to satisfy tax withholding obligations related to restricted stock unit vesting.

Anthony J. Recupero, President of Commercial Operations at SI-BONE, Inc., sold shares of common stock to cover tax withholding obligations in connection with the vesting of restricted stock units.

SI-BONE, Inc.'s SVP, Operations & Administration and Chief Legal Officer, Michael A. Pisetsky, sold 3,127 shares of common stock on July 2, 2025, solely to cover tax withholding obligations related to the vesting of restricted stock units.

SI-BONE, Inc. Director Jeffrey W. Dunn reported the grant of 8,675 restricted stock units and a subsequent 'sell to cover' transaction of 3,377 common shares for tax obligations, as detailed in a recent SEC Form 4 filing.

SI-BONE, Inc. Director Thomas A. West was granted 8,675 restricted stock units, increasing his total beneficial ownership to 26,990 shares, as disclosed in a recent SEC Form 4 filing.

SI-BONE, Inc. Director Mika Nishimura was granted 8,675 restricted stock units (RSUs) on June 5, 2025, as part of her compensation, which will vest upon specific conditions.

SI-BONE, Inc. Director Jeryl L. Hilleman was granted 8,675 restricted stock units (RSUs) on June 5, 2025, as part of her compensation, which will vest upon continued service.

SI-BONE, Inc. Director Gregory K. Hinckley reported the acquisition of 8,675 restricted stock units, increasing his beneficial ownership in the company.

SI-BONE, Inc. Director John Gordon Freund reported the acquisition of 8,675 shares of common stock through a restricted stock unit grant, vesting upon continued service.

SI-BONE, Inc. Director Timothy E. Davis Jr. has reported the acquisition of 8,675 restricted stock units (RSUs) as part of his compensation, aligning his interests with shareholders.